Home About Us Contact Us

 

Table of Content Volume 13 Issue 3 - March 2020

 

A study of prevalence of hypertensive retinopathy at tertiary health care center

 

Priyadarshini Cholera1, Manish Pendse2*

 

{1Associate Professor, Department of Ophthalmology} {2Associate Professor, Department of Medicine} D Y Patil Medical College, Nerul, Navi Mumbai, Maharashtra, INDIA.

Email: drmanishpendse@gmail.com

 

Abstract              Background: nearly 26% of the adult population worldwide is affected by Hypertension. Kearney and colleagues estimated that the prevalence of hypertension in 2000 was 26% Aims and Objectives: To study prevalence of hypertensive retinopathy at tertiary health care center. Methodology: This was a cross sectional study carried out in the department of Ophthalmology during the one year period i.e. April 2018 to April 2019 so during the one year period those patients with diagnosed as Hypertensive and referred to Ophthalmology department for the routine retinal examination by taking the written and explained consent were included into the study . All details of the patients were noted and entered to excel sheet and analyzed by excel software for windows 10. Results: In our study we have seen that the prevalence of retinopathy was common in the age group >80 were 83.33%, followed by 70-80 were 68.62%, 60-70 were 65.3%, 50-60 were 53.83%, 40-50 were 45.00%, 30-40 were 25.00% and overall prevalence was 53.81%. The majority of the patients were Male i.e. 73.23% and 26.77 were Female. By Keith Wagener classification the prevalence of Grade I retinopathy was 51.18%, followed by Grade II was 27.55%, Grade III was 22.83%, Grade IV was 7.87 Conclusion: The hypertensive retinopathy is a very common problem specially in the males and old age hence these high risk patients should regularly screened for Hypertensive retinopathy and adequate measures should be taken to control BP and Hypertensive retinopathy.

Key words: hypertensive retinopathy, Keith Wagener classification

 

INTRODUCTION

nearly 26% of the adult population worldwide is affected by Hypertension. Kearney and colleagues estimated that the prevalence of hypertension in 2000 was 26% of the adult population globally and that in 2025 the prevalence would increase by 24% in developed countries and 80% in developing countries.1 Hypertensive retinopathy is a relatively common condition in ophthalmic practice as ophthalmoscopy of a hypertensive patient forms an indispensable aid in its assessment, and prognostication but even with frequent detection of hypertensive retinopathy, its value vis a vis general systemic complication is seldom brought out. Hypertensive retinopathy is a spectrum of retinal signs related pathologically to retinal microvascular damage from elevated blood pressure.3 It is well documented that hypertensive retinopathy is associated with cardiovascular morbidity and mortality.4-6 Therefore, prevalence and spectrum of hypertensive retinopathy in the population reflects the status of hypertension control and the associated risks for cardiovascular events. In clinical management of hypertensive patients, hypertensive retinopathy can be used in cardiovascular risk assessment 6 and can be an indication for initiating anti-hypertensive therapy, even in persons with pre-hypertension or stage one hypertension7,8. So, in our study we have seen the prevalence of hypertensive retinopathy at tertiary health care center.

 

 

METHODOLOGY

This was a cross sectional study carried out in the department of Ophthalmology during the one year period i.e. April 2018 to April 2019 so during the one year period those patients with diagnosed as Hypertensive and referred to Ophthalmology department for the routine retinal examination by taking the written and explained consent were included into the study. The patients diagnosed as retinopathy by Senior Ophthalmic surgeon various classical features of Hypertensive retinopathy on the Ophthalmoscope and if the retinopathy was present then it was classified into Keith Wagener grades i.e. I to IV2


 

Grade I

Slight or Modest Narrowing of the Retinal Arterioles, with an Arteriovenous Ratio of ≥1:2

Grade II

Grade I + Modest to severe narrowing of retinal arterioles with an arteriovenous ratio <1:2 or arteriovenous nicking

Grade III

Grade II + Soft exudates or flame-shaped haemorrhages

Grade IV

Grade III + Bilateral optic disc nerve oedema

All details of the patients were noted and entered to excel sheet and analyzed by excel software for windows 10.

 


RESULT

Table 1: Distribution of the patients as per the age

Age

No.

Total referred for Opthalm.

Percentage (%)

30-40

12

48

25.00

40-50

17

37

45.00

50-60

21

39

53.83

60-70

32

49

65.3

70-80

35

51

68.62

>80

10

12

83.33

Overall

127

236

53.81

The prevalence of retinopathy was common in the age group >80 were 83.33%, followed by 70-80 were 68.62%, 60-70 were 65.3%, 50-60 were 53.83%, 40-50 were 45.00%, 30-40 were 25.00% and overall prevalence was 53.81%.

Graph 1: Distribution of the patients as per the age

 

Table 2: Distribution of the patients as per the sex

Sex

No.

Percentage (%)

Male

93

73.23

Female

34

26.77

Total

127

100.00

The majority of the patients were Male i.e. 73.23% and 26.77 were Female.

Table 3: Distribution as per the grade of retinopathy

Keith Wagener

No.

Percentage

Grade I

65

51.18

Grade II

30

27.55

Grade III

22

22.83

Grade IV

10

7.87

By Keith Wagener classification the prevalence of Grade I retinopathy was 51.18%, followed by Grade II was 27.55%, Grade III was 22.83%, Grade IV was 7.87.

 

DISCUSSION

Elevated blood pressure is the most important public health problem in developing and developed countries. It is common, asymptomatic, readily detectable, usually treatable, and often leads to lethal complications if left untreated. Hypertensive retinopathy is among the vascular complications of essential hypertension. It is known that the auto-regulation of retinal circulation fails as blood pressure increases beyond a critical limit. However, elevated blood pressure alone does not fully account for the extent of retinopathy. 9 Systemic hypertension is one of the major causes of the global burden of disease. More than a hundred crore people have elevated blood pressure which results in an estimated ninety lakh deaths per year.10 ACC/AHA classified the people with BP of less than 120/80 as normal, systolic BP of 120 to 129 is defined as elevated blood pressure, systolic BP between 130 and 139 and diastolic BP between 80 and 89 is classified as stage-1 and the values above are classified as stage-2.11 Target Organ damage involving cerebrovascular system, cardiovascular system, kidney and retina are the common complications of the poorly controlled blood pressure.3 Linear association between various stages of HTR and both clinical and subclinical cardiovascular and cerebrovascular mortality and morbidity has been widely studied.13 The incidence of hypertensive retinopathy increases in proportion with the duration and the severity of hypertension.14 In our study we have seen that The prevalence of retinopathy was common in the age group >80 were 83.33%, followed by 70-80 were 68.62%, 60-70 were 65.3%, 50-60 were 53.83%, 40-50 were 45.00%, 30-40 were 25.00% and overall prevalence was 53.81%. The majority of the patients were Male i.e. 73.23% and 26.77 were Female. By Keith Wagener classification the prevalence of Grade I retinopathy was 51.18%, followed by Grade II was 27.55%, Grade III was 22.83%, Grade IV was 7.87. These findings are similar to Pun CB et al. 15 they found the mean age of the patients was 60.58 ±12.26 standard deviation. In our study 56.5% patients had hypertensive retinopathy. Of which 31% had grade I, 19% had grade II, 6% had grade III and 0.5% had grade IV hypertensive retinopathy. The ratio of hypertensive retinopathy among male and female was 1.7:1.

 

CONCLUSION

The hypertensive retinopathy is a very common problem specially in the males and old age hence these high-risk patients should regularly screen for Hypertensive retinopathy and adequate measures should be taken to control BP and Hypertensive retinopathy.

 

REFERENCES

  1. Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: Analysis of worldwide data. Lancet. 2005; 365: 217-223.
  2.  Downie LE , Hodgson LADsylva C, et al.. Hypertensive retinopathy: comparing the Keith-Wagener-Barker to a simplified classification. J Hypertens2013;31(5):960-965.
  3. Kanski JJ, Bowling B. Clinical ophthalmology: a systematic approach. Elsevier Health Sciences; 2011.
  4.  Wong TY, Klein R, Couper DJ, Cooper LS, Shahar E, Hubbard LD, et al.. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet. 2001;358(9288):1134–40. doi: 10.1161/01.STR.0000195134.04355.e5
  5. Wong TY, Klein R, Sharrett AR, Duncan BB, Couper DJ, Tielsch JM, et al.. Retinal arteriolar narrowing and risk of coronary heart disease in men and women: the Atherosclerosis Risk in Communities Study. JAMA. 2002;287(9):1153–9.
  6. Grosso A, Veglio F, Porta M, Grignolo FM, Wong TY. Hypertensive retinopathy revisited: some answers, more questions. Br J Ophthalmol. 2005;89(12):1646–54. doi: 10.1136/bjo.2005.072546
  7.  Baker ML, Hand PJ, Wang JJ, Wong TY. Retinal signs and stroke: revisiting the link between the eye and brain. Stroke. 2008;39(4):1371– 9. doi: 10.1161/STROKEAHA.107.496091
  8.  Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, et al.. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ. 1999;319(7210):630–5. doi: https:// doi.org/10.1136/bmj.319.7210.630
  9. Liebreich R. Bright's disease at diagnosis-shear ophthalmoscopy Albercht Von Graefes. Arch Ophthalmol 859;5:265-8.
  10. Kotchen TA. Hypertensive vascular disease. In: Jameson JL, Fauci AS, Kasper DL, et al., eds. Harrison's principles of internal medicine. 20th New York, NY: McGraw-Hill 2018.
  11. Whelton PKCarey RMAronow WS, et al.. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2018;71(19):e127-e248.
  12. Kabedi NN, Mwanza JC, Lepira FB, et al.. Hypertensive retinopathy and its association with cardiovascular, renal and cerebrovascular morbidity in Congolese patients. Cardiovasc J Afr 2014;25(5):228-232.
  13. Wong TY, McIntosh R. Hypertensive retinopathy signs as risk indicators of cardiovascular morbidity and mortality. Br Med Bull 2005;73-74:57-70.
  14. Modi P, Arsiwalla T. Hypertensive retinopathy. (Updated 2019 Jan 23). In: StatPearls (Internet). Treasure Island (FL): StatPearls Publishing 2018
  15. Pun CB , Tuladhar S. Profile of Hypertensive Retinopathy in a Tertiary Centre in Western Nepal. Journal of Gandaki Medical College-Nepal. January-June 2019;12(01):22-24.


 



 

Policy for Articles with Open Access:

Authors who publish with MedPulse International Journal of Community Medicine (Print ISSN: 2579-0862) (Online ISSN: 2636-4743) agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.